RE:RE:class war
azzymaa wrote: why doesn't pmn just get bought out by a bigger company if pmn310 is so valuable?
It's a great question with many possible answers.
Consider Moderna, the mrna vaccine tech wasn't that valuable until it was.
Consider Biogen, they had an in-house strategy and careers depended upon it.
Consider Gene and Elliot, they planned for a quick-out but didn't have the connections or street cred to pull it off.
Consider the history of public microcap pharmas, there aren't many cause they run out of money long before getting to P3
Consider big pharma, it works with the biggest investment banks to direct almost all institutional money away from potential competition, and it mostly owns the regulators who can ensure reaching P3 is prohibitively expensive, or make the path faster and cheaper.
Money talks but people make decisions.